Liquid Biopsy – What Is It?

A liquid biopsy is a test that is performed on a sample of blood taken from a patient. The test analyzes the blood sample and looks for traces of cancer DNA from tumor cells that are often present in the blood. Multiple blood samples over a period of time allow physicians and doctors to examine […]
10 Reasons why Biomark BUX is a Buy and Long-term Hold

The article presented on this page may contain forward-looking statements. These statements relate to future events or future financial performance. Any statements that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, and similar statements) should be considered forward looking statements. […]
BioMark Diagnostics and Phytronix Technologies Strategic Technology Integration Partnership

The Right Leadership and Technology Partnerships designed to deliver clinical solutions to cancer care management. Dr. Haince bring solid capabilities in clinical development and commercialization of cancer diagnostic tests in N. America, Accreditation and core lab management expertise, scientific rigour and business development capabilities to BioMark as GM and CSO (Chief Scientist Officer). At Diagnocure, […]
BIOMARK TO OPEN A DIAGNOSTIC LABORATORY IN QUÉBEC

Vancouver, British Columbia – (April 29, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce today that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. (“BDS”) will be operating a diagnostic laboratory in Quebec, Canada, which will primarily serve to advance the clinical validation of its proprietary liquid biopsy […]
BIOMARK ANNOUNCES EXERCISE OF WARRANTS AND GAIN DTC ELIGIBILITY FOR ITS COMMON SHARES

Vancouver, British Columbia – (April 21, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce today the agreement by several long-time strategic accredited investors and insiders to exercise approximately 2,000,000 warrants issued in connection with the Company’s private placement of units completed in April 2019, with the warrant […]
Alberta Research to Spot Early Stage Lung Cancer

Earlier and faster cancer detection is underway in Alberta Mikenomics | April 6, 2021 Earlier and faster cancer detection is the goal of research underway here in Alberta.With funding from the Spark Grants, The Metabolomics Innovation Centre (TMIC) based at the University of Alberta is leading the new effort. With funding from the Spark Grants, The Metabolomics Innovation Centre (TMIC) based […]
A Simple Blood Test to Detect Lung Cancer

A new project funded by the Canadian Cancer Society (CCS) could transform how lung cancer is detected and help save lives. Dr. David Wishart March 18, 2021 A new project funded by the Canadian Cancer Society (CCS) could transform how lung cancer is detected and help save lives. Lung cancer is the most commonly diagnosed […]
Long-Time Cardiologist Dr. Myron Weisfeldt Who “Changed Face of Hopkins” Receiving American Heart Association’s Distinguished Watkins-Saunders Award for Commitment to Overcoming Disparities

Dr. Myron “Mike” Weisfeldt is the 2021 recipient of the American Heart Association’s distinguished Watkins-Saunders Award. Dr. Myron “Mike” Weisfeldt MARCH 9, 2021 Dr. Myron “Mike” Weisfeldt has been a leader in advancing diversity at Johns Hopkins since the early 1970s and is the 2021 recipient of the American Heart Association’s distinguished Watkins-Saunders Award. “Mike […]
3 Cancer Diagnostic Stocks To Watch Following Roche’s GenMark Buy

Biotech companies are showing leadership in early detection of cancer. March 16, 2021 Melanie Schaffer , Benzinga Staff Writer In January, Exact Sciences Corporation EXAS 1.59% announced it completed its acquisition of Thrive Earlier Detection Corp. and got Thrive’s blood-based multi-cancer detection technology. Why It Matters: Early detection of cancer greatly increases the survival rate and smaller biotech companies are showing leadership skills in […]
U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test

Mar 16, 2021 | staff reporter NEW YORK — BioMark Diagnostics said on Tuesday that its collaborators at the University of Alberta’s Metabolomics Innovation Centre have been awarded a C$150,000 (US$120,327) grant to evaluate the company’s metabolite biomarker panel for early lung cancer detection. The funding is being provided through a cancer technology grant program sponsored by […]